Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.

The finding effectively paves the way for continued use of atrazine, a widely used herbicide that has been linked to birth defects and cancer in humans.

© Julie Ingwersen/Reuters